Advertisement
Robin Smith, M.D., NeoStem's CEO and Chairman of the board of directors,will be available for one-on-one meetings with institutional investors onMarch 15 at the conference.
Advertisement
About NeoStem, Inc.
NeoStem, Inc. is engaged in the development of stem cell-based therapies,pursuit of anti-aging initiatives and building of a network of adult stem cellcollection centers in the U.S. and China that are focused on enabling peopleto donate and store their own (autologous) stem cells for their personal usein times of future medical need. The Company also has licensed various stemcell technologies, including a worldwide exclusive license to VSEL(TM)technology which uses very small embryonic-like stem cells, shown to haveseveral physical characteristics that are generally found in embryonic stemcells, and is pursuing the licensing of other technologies for therapeutic use.NeoStem's majority-controlled Chinese pharmaceutical operation, Suzhou Erye,manufactures and distributes generic antibiotics in China. For moreinformation, please visit: http://www.neostem.com .Presentation Date: Monday, March 15, 2010 Time: 8 a.m. Pacific Time Venue: The Ritz-Carlton, Laguna Niguel One Ritz Carlton Dr Dana Point, CA 92629
SOURCE NeoStem, Inc.